Clinical Trial Update: A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the Latanoprost punctal plug delivery system (L-PPDS) for ocular hypertension or open-angle glaucoma has completed; the update confirms…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Latanoprost punctal plug delivery system (L-PPDS) (latanoprost)

Snippet

Sponsor: Mati Therapeutics Inc. | Conditions: Ocular Hypertension, Open Angle Glaucoma | Phase 2 | Status: COMPLETED